D. E. Shaw & Co., Inc. Iqvia Holdings Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 310,149 shares of IQV stock, worth $59.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

310,149

Holding current value

$59.8 Million

% of portfolio

0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$206.81 - $251.55 $8.6 Million - $10.5 Million	41,597 Added 15.49%	310,149 $73.5 Million
Q2 2024 Aug 14, 2024	BUY	$211.18 - $248.87 $42 Million - $49.5 Million	198,808 Added 285.05%	268,552 $56.8 Million
Q1 2024 May 15, 2024	BUY	$208.23 - $259.1 $14.1 Million - $17.6 Million	67,744 Added 3387.2%	69,744 $17.6 Million
Q4 2023 Feb 14, 2024	SELL	$177.16 - $232.73 $212,592 - $279,276	-1,200 Reduced 37.5%	2,000 $462,000
Q3 2023 Nov 14, 2023	SELL	$196.75 - $231.96 $39,350 - $46,392	-200 Reduced 5.88%	3,200 $629,000
Q2 2023 Aug 14, 2023	SELL	$183.66 - $224.77 $30.9 Million - $37.8 Million	-168,224 Reduced 98.02%	3,400 $764,000
Q1 2023 May 15, 2023	SELL	$188.0 - $240.65 $816,108 - $1.04 Million	-4,341 Reduced 2.47%	171,624 $34.1 Million
Q4 2022 Feb 14, 2023	BUY	$172.45 - $226.53 $24.8 Million - $32.6 Million	143,711 Added 445.56%	175,965 $36 Million
Q3 2022 Nov 14, 2022	SELL	$181.14 - $248.26 $10.5 Million - $14.3 Million	-57,695 Reduced 64.14%	32,254 $5.84 Million
Q2 2022 Aug 15, 2022	SELL	$196.45 - $252.29 $5.67 Million - $7.28 Million	-28,846 Reduced 24.28%	89,949 $19.5 Million
Q1 2022 May 16, 2022	SELL	$210.56 - $273.58 $61,904 - $80,432	-294 Reduced 0.25%	118,795 $27.5 Million
Q4 2021 Feb 14, 2022	SELL	$238.37 - $282.61 $7.98 Million - $9.46 Million	-33,483 Reduced 21.95%	119,089 $33.6 Million
Q3 2021 Nov 15, 2021	SELL	$239.54 - $265.23 $66.8 Million - $73.9 Million	-278,664 Reduced 64.62%	152,572 $36.5 Million
Q2 2021 Aug 16, 2021	SELL	$198.06 - $246.77 $32.2 Million - $40.1 Million	-162,588 Reduced 27.38%	431,236 $104 Million
Q1 2021 May 17, 2021	SELL	$173.0 - $194.59 $86 Million - $96.8 Million	-497,340 Reduced 45.58%	593,824 $115 Million
Q4 2020 Feb 16, 2021	SELL	$153.99 - $180.39 $70.9 Million - $83 Million	-460,378 Reduced 29.67%	1,091,164 $196 Million
Q3 2020 Nov 16, 2020	SELL	$141.28 - $169.75 $21.1 Million - $25.3 Million	-149,145 Reduced 8.77%	1,551,542 $245 Million
Q2 2020 Aug 14, 2020	SELL	$100.04 - $153.06 $12.6 Million - $19.3 Million	-125,827 Reduced 6.89%	1,700,687 $241 Million
Q1 2020 May 15, 2020	SELL	$84.0 - $166.11 $21.2 Million - $41.8 Million	-251,875 Reduced 12.12%	1,826,514 $197 Million
Q4 2019 Feb 14, 2020	BUY	$137.59 - $155.95 $1.14 Million - $1.3 Million	8,312 Added 0.4%	2,078,389 $321 Million
Q3 2019 Nov 14, 2019	SELL	$148.25 - $161.46 $8.03 Million - $8.74 Million	-54,149 Reduced 2.55%	2,070,077 $309 Million
Q2 2019 Aug 14, 2019	BUY	$132.28 - $160.9 $43.8 Million - $53.3 Million	331,390 Added 18.48%	2,124,226 $342 Million
Q1 2019 May 15, 2019	BUY	$109.96 - $144.45 $42.4 Million - $55.7 Million	385,264 Added 27.37%	1,792,836 $258 Million
Q4 2018 Feb 14, 2019	BUY	$105.7 - $130.35 $4 Million - $4.94 Million	37,871 Added 2.76%	1,407,572 $164 Million
Q3 2018 Nov 14, 2018	BUY	$99.3 - $130.77 $17.2 Million - $22.7 Million	173,609 Added 14.51%	1,369,701 $178 Million
Q2 2018 Aug 14, 2018	BUY	$94.85 - $105.95 $58 Million - $64.8 Million	611,387 Added 104.56%	1,196,092 $119 Million
Q1 2018 May 15, 2018	SELL	$95.23 - $106.01 $29.9 Million - $33.3 Million	-314,299 Reduced 34.96%	584,705 $57.4 Million
Q4 2017 Feb 14, 2018	BUY	$95.0 - $108.56 $85.4 Million - $97.6 Million	899,004	899,004 $88 Million

Others Institutions Holding IQV

# of Institutions

1,137

Shares Held

142M

Call Options Held

828K

Put Options Held

951K

View Full List

About IQVIA HOLDINGS INC.

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.8B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

More about IQV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account